Beam Therapeutics Inc.
BEAM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,489,393 | $1,734,938 | $1,718,152 | $2,054,035 |
| - Cash | $267,960 | $282,132 | $527,907 | $281,967 |
| + Debt | $151,420 | $154,803 | $158,129 | $161,425 |
| Enterprise Value | $2,372,853 | $1,607,609 | $1,348,374 | $1,933,493 |
| Revenue | $9,698 | $8,466 | $7,470 | $30,067 |
| % Growth | 14.6% | 13.3% | -75.2% | – |
| Gross Profit | -$100,071 | -$93,292 | -$91,346 | -$71,377 |
| % Margin | -1,031.9% | -1,102% | -1,222.8% | -237.4% |
| EBITDA | -$107,168 | -$114,613 | -$113,758 | -$94,594 |
| % Margin | -1,105.1% | -1,353.8% | -1,522.9% | -314.6% |
| Net Income | -$112,728 | -$102,291 | -$109,270 | -$90,354 |
| % Margin | -1,162.4% | -1,208.3% | -1,462.8% | -300.5% |
| EPS Diluted | -1.1 | -1 | -1.24 | -1.09 |
| % Growth | -10% | 19.4% | -13.8% | – |
| Operating Cash Flow | -$81,479 | -$76,450 | -$103,884 | -$76,365 |
| Capital Expenditures | -$5,011 | -$3,136 | -$3,065 | -$2,970 |
| Free Cash Flow | -$86,490 | -$79,586 | -$106,949 | -$79,335 |